CURI Insider Notice: 50,000 Shares via Needham on Aug 25, 2025

Rhea-AI Filing Summary

CuriosityStream (CURI) filed a Form 144 proposing to sell 50,000 shares of Common stock through Needham and Company LLC on 08/25/2025. The filing lists an aggregate market value of $222,500 based on the proposed sale and notes 57,929,733 shares outstanding, indicating the proposed sale equals a small fraction of the outstanding stock. The shares were acquired on 10/14/2020 in a SPAC conversion from the issuer. The filer reports no sales in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Full regulatory disclosure filed under Rule 144 with broker and acquisition details
• Proposed sale size is small relative to total outstanding shares (~0.09%), limiting market impact
• No reported sales in prior three months, reducing concerns about an ongoing sell program

Negative

• Insider proposed to sell shares, which could be viewed negatively by some investors despite small size

Insights

Securities Analyst

TL;DR: Small insider disposition proposed; unlikely to move market but should be tracked for timing and volume.

The Form 144 shows a proposed sale of 50,000 common shares via Needham on 08/25/2025 with an aggregate value of $222,500 versus 57.93 million shares outstanding. This represents roughly 0.09% of the outstanding shares, so the transaction is immaterial from a market-capitalization perspective. The acquisition date is 10/14/2020 via SPAC conversion, confirming these are not recent purchases. Absence of sales in the past three months reduces immediate pattern-of-sale concerns. Overall impact on valuation or liquidity is negligible but disclosure is appropriate under Rule 144.

Corporate Governance Expert

TL;DR: Proper compliance with Rule 144 documented; filing contains customary signer representations.

The filing contains required broker details, acquisition history showing SPAC conversion, and the mandatory signer representation about lack of undisclosed material information. No other compliance issues or material qualifiers are present. From a governance standpoint, the notice demonstrates adherence to disclosure rules for proposed insider sales. The small size of the sale mitigates shareholder governance concerns, though investors may note insider liquidity actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Needham and Company LLC 250 Park Avenue 10th Floor New York NY 10177	50000	222500.00	57929733	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/14/2020	SPAC Conversion	Issuer			50000	10/14/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CuriosityStream's (CURI) Form 144 report?

It reports a proposed sale of 50,000 common shares through Needham on 08/25/2025 with an aggregate market value of $222,500.

How large is the proposed sale relative to CURI's outstanding shares?

The 50,000 shares are about 0.09% of the 57,929,733 shares outstanding reported in the filing.

When were the shares being sold originally acquired?

The shares were acquired on 10/14/2020 via a SPAC conversion from the issuer as stated in the filing.

Has the filer sold any CURI securities in the past three months?

No; the filing lists "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed sale?

Needham and Company LLC (250 Park Avenue, 10th Floor, New York, NY) is listed as the broker.